Working with an undisclosed startup, EditForce is already using its DNA-binding PPR technology to build more potent engineered T cell therapies for cancer patients. And with a Nagoya-based pharma ...
In addition to the iPSC-related services, Creative Biolabs provides a custom neural differentiation service, enabling researchers to further differentiate iPSCs into neural-specific cell types.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback